{"top_spans": [[0, 0], [1, 1], [2, 3], [4, 4], [5, 6], [5, 8], [8, 8], [9, 9], [11, 11], [13, 22], [17, 22], [17, 24], [23, 23], [24, 24], [25, 25], [26, 31], [32, 32], [33, 41], [34, 40], [37, 41], [38, 41], [43, 48], [43, 50], [46, 48], [46, 50], [46, 51], [51, 51], [52, 52], [53, 53], [54, 54], [65, 65], [66, 66], [72, 72], [73, 73], [75, 76], [80, 84], [88, 90], [88, 92], [88, 95], [94, 94], [94, 95], [96, 96], [97, 101], [97, 105], [99, 101], [100, 101], [100, 105], [107, 107], [107, 115], [109, 111], [109, 115], [109, 116], [111, 115], [113, 115], [117, 117], [118, 121], [128, 130], [128, 132], [128, 135], [133, 133], [135, 135], [140, 140], [148, 148], [167, 168], [169, 169], [170, 170], [174, 178], [179, 179], [179, 187], [179, 188], [180, 180], [180, 187], [180, 188], [186, 187], [187, 187]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["argenx", "announces", "new", "cusatuzumab", "argx-110", "aml", "data", "in", "abstracts", "published", "in", "connection", "with", "60th", "american", "society", "of", "hematology", "annual", "meeting", "and", "exposition", "argenx", "euronext", "nasdaq", "argx", "a", "clinical", "-", "stage", "biotechnology", "company", "developing", "a", "deep", "pipeline", "of", "differentiated", "antibody", "-", "based", "therapies", "for", "the", "treatment", "of", "severe", "autoimmune", "diseases", "and", "cancer", "today", "announced", "updated", "data", "from", "the", "ongoing", "phase", "1", "dose", "-", "escalation", "part", "of", "its", "phase", "1", "2", "clinical", "trial", "of", "cusatuzumab", "argx-110", "in", "acute", "myeloid", "leukemia", "aml", "and", "high", "-", "risk", "myelodysplastic", "syndromes", "mds", "as", "of", "the", "data", "cut", "-", "off", "on", "july", "16", "2018", "a", "92", "11", "12", "patients", "overall", "response", "rate", "orr", "was", "observed", "with", "42", "of", "patients", "achieving", "minimal", "residual", "disease", "mrd", "negativity", "the", "median", "response", "duration", "was", "6", "9", "months", "as", "of", "the", "data", "cut", "-", "off", "date", "cancer", "cusatuzumab", "tumor", "immunology", "lab", "of", "prof", "a", "f", "ochsenbein", "nicolas", "leupin", "sec", "otto", "naegeli", "mds", "product", "development", "solid", "tumors", "ctcl", "chief", "medical", "officer", "mechanism", "of", "action", "university", "of", "bern", "american", "society", "of", "hematology", "aml", "orr", "hematology", "university", "hospital", "of", "z\u00fcrich", "argenx", "belgium", "ghent", "netherlands", "breda", "us", "securities", "and", "exchange", "commission", "prof", "manz", "aza", "mrd"], "clusters": []}